Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] traded at a high on Thursday, posting a 33.49 gain after which it closed the day’ session at $14.63.
The results of the trading session contributed to over 15995805 shares changing hands. Over the past one week, the price volatility of Tonix Pharmaceuticals Holding Corp stands at 30.11% while the volatility over the past one month is 19.88%.
The market cap for TNXP stock reached $81.79 million, with 155.63 million shares outstanding and 5.59 million shares in the current float. Compared to the average trading volume of 1.65M shares, TNXP reached a trading volume of 15995805 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Tonix Pharmaceuticals Holding Corp [TNXP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNXP shares is $325.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNXP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Tonix Pharmaceuticals Holding Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 18, 2022. The new note on the price target was released on April 18, 2019, representing the official price target for Tonix Pharmaceuticals Holding Corp stock. Previously, the target price had yet another raise to $6, while ROTH Capital analysts kept a Buy rating on TNXP stock.
The Average True Range (ATR) for Tonix Pharmaceuticals Holding Corp is set at 3.67, with the Price to Sales ratio for TNXP stock in the period of the last 12 months amounting to 7.24. The Price to Book ratio for the last quarter was 30.68, with the Price to Cash per share for the same quarter was set at 5.05.
How has TNXP stock performed recently?
Tonix Pharmaceuticals Holding Corp [TNXP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 78.85. With this latest performance, TNXP shares dropped by -3.81% in over the last four-week period, additionally sinking by -12.86% over the last 6 months – not to mention a drop of -98.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNXP stock in for the last two-week period is set at 50.33, with the RSI for the last a single of trading hit 61.46, and the three-weeks RSI is set at 47.21 for Tonix Pharmaceuticals Holding Corp [TNXP]. The present Moving Average for the last 50 days of trading for this stock 23.31, while it was recorded at 9.73 for the last single week of trading, and 72.24 for the last 200 days.
Tonix Pharmaceuticals Holding Corp [TNXP]: Deeper insight into the fundamentals
Tonix Pharmaceuticals Holding Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.78 and a Current Ratio set at 3.33.
Earnings analysis for Tonix Pharmaceuticals Holding Corp [TNXP]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNXP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tonix Pharmaceuticals Holding Corp go to 78.59%.
